The metabolic pathways regulated by FXR mainly include glucose, sterol metabolism, and lipid, and are believed to have the potential to improve conditions such as obesity, liver damage, and chronic inflammatory diseases (Xiang et al., 2021). Here, NR1H4 is linked to obesity due to melanocortin 4 receptor deficiency.